Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Muzahir Tayebjee, S Nader, Andrew Blann, David Beevers, Robert Macfadyen, Gregory Lip
Research output: Contribution to journal › Article
118Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)'. Together they form a unique fingerprint.